The study revealed that a gene common in some bats can reduce the production of the SARS-CoV-2 virus by up to 90%, which could help lead to new medical approaches to combating viral diseases.

There are no approved vaccines or treatments for Sudan virus disease, which has a 40–70% fatality rate. To curb the ongoing outbreak, Uganda has deployed—under a clinical trial setting—a vaccine ...

WHO and the Uganda Health Ministry have launched a first-ever vaccine trial for the species of Ebola at the center of an ongoing outbreak in Uganda’s capital city.

Amid a new Ebola outbreak in Kampala, Uganda, the World Health Organization has kicked off a vaccine trial. This is the first ...

A laboratory holding Ebola and other dangerous pathogens in the eastern DR Congo city of Goma—which has been seized by the ...

Ebola is rare, deadly and has multiple variants. There is a vaccine for the Zaire type. Now, trials for another strain are ...

"If we don't know what the wildlife host is, we can't know how, where or when that will be." Scientists make major ...

Cryo-EM structure of Sudan ebolavirus glycoprotein complexed with its human endosomal receptor NPC1 - (https://www.nature.com ...

The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist. To address this critical ...

A new study finds that the Sudan virus, a deadly Ebola relative, binds to human NPC1 receptors with nine times greater ...

Sudan virus (SUDV) can infect people to cause Sudan virus disease (SVD). Right now, an outbreak of SVD has been detected in ...

A fatal virus has been discovered in shrews in Alabama, sparking concerns about potential contagion to humans. The Camp Hill ...